Advertisement

Month: December 2019

November 2019 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]

Read More

November 2019 Briefing – Surgery

Here are what the editors at HealthDay consider to be the most important developments in Surgery for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rates of Postoperative Mortality High for Frail, Very […]

Read More

November 2019 Briefing – Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Study Supports PSA Screening for Male BRCA2 Carriers […]

Read More

November 2019 Briefing – Internal Medicine

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rates of Postoperative Mortality High for Frail, […]

Read More

November 2019 Briefing – Critical Care

Here are what the editors at HealthDay consider to be the most important developments in Critical Care for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for […]

Read More

November 2019 Briefing – Emergency Medicine

Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for […]

Read More

November 2019 Briefing – Otolaryngology

Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Object-Related Aspiration Deaths Decreased Among Children WEDNESDAY, Nov. […]

Read More

November 2019 Briefing – Nephrology

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]

Read More

November 2019 Briefing – Pathology

Here are what the editors at HealthDay consider to be the most important developments in Pathology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Antimicrobial Resistance Patterns Examined for Adult, Peds HAIs […]

Read More

November 2019 Briefing – Radiology

Here are what the editors at HealthDay consider to be the most important developments in Radiology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fewer Interval Cancers Diagnosed With Supplemental MRI for […]

Read More

November 2019 Briefing – Anesthesiology

Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]

Read More

November 2019 Briefing – Cosmetic Surgery

Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for […]

Read More

November 2019 Briefing – Geriatrics

Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rates of Postoperative Mortality High for Frail, Very […]

Read More

November 2019 Briefing – Pain Management

Here are what the editors at HealthDay consider to be the most important developments in Pain Management for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Cancer Patients Need More Info on Side […]

Read More

November 2019 Briefing – Pharmacy

Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for Status […]

Read More

For latest news and updates
Email-id is invalid